|
ASIA |
PRIMARY DRUG AMONG PERSONS TREATED FOR DRUG PROBLEMS IN ASIA
2017 (or latest year available)
|
Country/Territory |
Source |
Treatment |
Distribution of main drugs in percentages* |
Treatment |
Data |
|||||||
|
Cannabis |
Opioids |
Cocaine |
ATS |
Tranquillizers |
Hallucinogens |
Solvents and |
Other † |
|||||
|
Afghanistan |
ARQ |
2015 |
7.2% |
92.8% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
18,609 |
a |
|
Armenia |
ARQ |
2015 |
3.4% |
95.1% |
0.0% |
0.0% |
1.5% |
0.0% |
0.0% |
0.0% |
267 |
|
|
Azerbaijan |
ARQ |
2017 |
6.3% |
81.2% |
0.0% |
0.0% |
12.5% |
0.0% |
0.0% |
0.0% |
2,802 |
a |
|
Bangladesh |
DAINAP |
2007/ 2009*** |
15.0% |
76.9% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
3,800 |
a |
|
Bhutan |
ARQ |
2010 |
|
|
|
|
|
|
|
|
74 |
|
|
Brunei Darussalam |
ARQ |
2017 |
0.0% |
0.0% |
0.0% |
100.0% |
0.0% |
0.0% |
0.0% |
0.0% |
103 |
|
|
China |
ARQ |
2016 |
0.0% |
100.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
162,000 |
k |
|
Cambodia |
DAINAP |
2017 |
0.0% |
0.9% |
0.0% |
98.8% |
0.0% |
0.0% |
0.0% |
0.3% |
15,737 |
|
|
Georgia |
ARQ/Gov. |
2017 |
14.3% |
73.8% |
0.1% |
5.4% |
4.7% |
0.0% |
0.0% |
1.6% |
10,370†† |
a |
|
Hong Kong SAR, China |
Gov./ARQ |
2008/ 2009*** |
6.0% |
57.9% |
0.0% |
8.7% |
0.0% |
0.0% |
0.0% |
27.4% |
12,557 |
j |
|
India |
ARQ |
2015-2016 |
26.2% |
49.2% |
0.3% |
0.4% |
11.1% |
|
3.0% |
9.8% |
15,250 |
k, d |
|
Indonesia |
ARQ |
2015-2017 |
|
|
|
|
|
|
|
|
26,054 |
k |
|
Iran (Islamic Republic of) |
ARQ |
2017 |
|
|
|
|
|
|
|
|
981,738 |
a |
|
Israel |
ARQ |
2017 |
0.0% |
100.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
5,350 |
k |
|
Japan |
Gov./DAINAP |
2005/ 2012*** |
2.3% |
0.0% |
0.0% |
55.1% |
0.0% |
0.0% |
14.5% |
28.2% |
18,131 |
|
|
Jordan |
ARQ |
2015 |
0.0% |
3.6% |
0.1% |
12.4% |
0.0% |
0.5% |
0.0% |
0.0% |
1,448 |
k |
|
Kazakhstan |
ARQ |
2017 |
2.6% |
50.3% |
0.0% |
1.1% |
0.3% |
|
0.8% |
44.9% |
5,102 |
|
|
Kuwait |
ARQ |
2009 |
28.4% |
31.2% |
0.5% |
22.3% |
16.1% |
0.0% |
1.5% |
0.0% |
197 |
d,f |
|
Kyrgyzstan |
ARQ |
2016 |
20.0% |
57.4% |
0.0% |
0.0% |
0.0% |
0.0% |
4.7% |
17.9% |
190 |
b, c |
|
Lao People's Democratic Republic |
DAINAP |
2015 |
0.1% |
0.7% |
0.0% |
99.2% |
0.0% |
0.0% |
0.0% |
0.0% |
1,419 |
|
|
Lebanon |
ARQ |
2017 |
22.3% |
38.5% |
20.5% |
9.1% |
8.3% |
0.0% |
0.0% |
1.3% |
2,341 |
k |
|
Macao SAR, China |
ARQ |
2016 |
3.3% |
43.3% |
3.3% |
11.3% |
0.3% |
|
|
30.7% |
573 |
k |
|
Malaysia |
ARQ |
2017 |
4.0% |
37.9% |
0.0% |
58.0% |
0.0% |
0.0% |
0.0% |
0.0% |
26,791 |
|
|
Maldives |
ARQ |
2003 |
13.0% |
87.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
126 |
d,e |
|
Mongolia |
ARQ |
2013 |
6.7% |
13.3% |
0.0% |
3.3% |
73.3% |
3.3% |
0.0% |
0.0% |
30 |
a |
|
Myanmar |
ARQ |
2017 |
0.3% |
83.0% |
0.0% |
13.0% |
0.0% |
0.0% |
0.0% |
3.6% |
7,536 |
a |
|
Nepal |
ARQ |
2006 |
|
|
|
|
|
|
|
|
900 |
a |
|
Oman |
ARQ |
2017 |
34.0% |
41.0% |
0.0% |
2.1% |
22.2% |
0.2% |
0.5% |
0.0% |
369 |
a |
|
Pakistan |
ARQ |
2017 |
|
|
|
|
|
|
|
|
1,064 |
b |
|
Philippines |
ARQ |
2017 |
18.1% |
0.7% |
0.6% |
79.6% |
0.0% |
1.0% |
0.0% |
0.1% |
4,045 |
a |
|
Qatar |
ARQ |
2008 |
|
|
|
|
|
|
|
|
150 |
a,d |
|
Korea (Republic of) |
ARQ |
2017 |
25.5% |
0.2% |
0.4% |
68.1% |
5.1% |
0.8% |
0.0% |
0.0% |
986 |
k, c,d |
|
Saudi Arabia |
ARQ |
2017 |
26.8% |
8.1% |
0.0% |
54.1% |
8.4% |
0.0% |
0.6% |
2.1% |
9,879 |
k |
|
Singapore |
ARQ |
2017 |
6.1% |
12.1% |
0.0% |
75.3% |
0.2% |
0.0% |
1.2% |
5.1% |
1,166 |
k |
|
Syrian Arab Republic |
ARQ |
2006 |
0.2% |
94.9% |
0.9% |
0.0% |
4.1% |
0.0% |
0.0% |
0.0% |
674 |
|
|
Sri Lanka |
ARQ |
2017 |
17.9% |
82.1% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
2,706 |
a |
|
Taiwan, Province of China |
NBCD DOH |
2009 |
0.1% |
73.1% |
|
22.3% |
4.2% |
|
|
|
19,125 |
d |
|
Tajikistan |
ARQ |
2016 |
0.5% |
91.8% |
|
|
|
|
|
|
560 |
a |
|
Thailand |
DAINAP |
2017 |
7.2% |
3.4% |
0.0% |
85.6% |
0.0% |
0.0% |
0.2% |
3.6% |
205,147 |
|
|
Turkmenistan |
ARQ |
2016 |
4.9% |
95.1% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
1,602 |
a |
|
United Arab Emirates |
ARQ |
2008/ 2009*** |
35.7% |
64.3% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
0.0% |
55 |
|
|
Uzbekistan |
ARQ |
2017 |
32.3% |
51.8% |
0.0% |
0.0% |
9.7% |
0.0% |
0.9% |
5.2% |
2,202 |
k |
|
Viet nam |
DAINAP |
2017 |
|
|
|
|
0.0% |
0.0% |
|
|
34,620 |
|
Notes
* Definitions of treatment interventions, recording practices (including counting rules) and methods for determining the primary drug of abuse differ from country to country; percentages may fail to add up to 100 percent owing to incomplete reporting, gaps in identifying primary drug of abuse and treatment for multiple drugs.
In cases where the total of the reported values by drug type exceeded the reported value for all treatment, the percentages are expressed as a proportion of the total.
** Figures may reflect the number of persons or treatment episodes depending on the Member State; figures exclude alcohol and nicotine.
*** If multiple years are given, the second year specified is for the number of people treated (second to the last column).
† In addition to miscellaneous and unspecified drugs, the category "Other" includes substances not under international control.
†† Georgia: Data represents treatment episodes rather than the number of treatment entrants.
Sources:
UNODC, Annual Report Questionnaire (ARQ)
UNODC Drug Abuse Information Network for Asia and the Pacific (DAINAP).
National Bureau of Controlled Drugs (NBCD), Department of Health (DOH), Taiwan
Government (Gov.)